Mirna Therapeutics appoints Peter Greenleaf to the Board of Directors

– USA, TX – Mirna Therapeutics, Inc. (Nasdaq:MIRN), a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics, today announced the appointment of Peter Greenleaf to the Company’s Board of Directors.…